Release Date: 16/03/09 11:09 Summary: Everest Masters Fund II update Price Sensitive: Yes Download Document 28.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%